Curcumin, a golden spice with a low bioavailability

Journal of Herbal Medicine

Volumn 5, Issue 2, 2015, Pages 57-70

  Siviero, Angelo ^a   Gallo, Eugenia ^a   Maggini, Valentina ^a   Gori, Luigi ^a   Mugelli, Alessandro ^a   Firenzuoli, Fabio ^a   Vannacci, Alfredo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Ayurveda; Bioavailability; Bioenancher; Curcuma longa; Curcumin; Nanoparticles; Phytosome; Piperine; Turmeric

Indexed keywords

ANDROGEN RECEPTOR; CELL ADHESION MOLECULE; CURCUMIN; CURCUMIN DERIVATIVE; CYCLODEXTRIN; CYTOKINE; ENZYME; GROWTH FACTOR; PENETRATION ENHANCING AGENT; PHOSPHOLIPID DERIVATIVE; PROTEIN KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CELL CYCLE ARREST; CURCUMA LONGA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG PENETRATION; DRUG SOLUBILITY; EMULSION; ENZYME INHIBITION; HUMAN; MICROEMULSION; PHARMACODYNAMICS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPICE;

EID: 84931567816     PISSN: 22108033     EISSN: 22108041     Source Type: Journal    
DOI: 10.1016/j.hermed.2015.03.001     Document Type: Review

References (112)

1. B.K. Adams, J. Cai, J. Armstrong, M. Herold, Y.J. Lu, and A. Sun EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism Anticancer Drugs 16 2005 263 275
2. H. Ahsan, and S.M. Hadi Strand scission in DNA induced by curcumin in the presence of Cu(II) Cancer Lett 124 1998 23 30
3. H. Ahsan, N. Parveen, N.U. Khan, and S.M. Hadi Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin Chem Biol Interact 121 2 1999 161 175
4. B.B. Aggarwal, A. Kumar, and M.S. Aggarwal Curcumin derived from turmeric (Curcuma longa): a spice for all seasons P.D. Debasis Bagchi, H.G. Preuss, Phytochemicals in cancer chemoprevention 2005 CRC Press New York 349 387
5. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res 23 2003 363 398
6. H.P. Ammon, and M.A. Wahl Pharmacology of Curcuma longa Planta Med 57 1991 1 7
7. P. Anand, H.B. Nair, B. Sung, A.B. Kunnumakkara, V.R. Yadav, and R.R. Tekmal Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo Biochem Pharmacol 79 3 2010 330 338
8. ® CG (Biocurcumax™), a novel bioenhanced preparation of curcumin Indian J Pharm Sci 70 4 2008 445 449
9. K.N. Baglole, P.G. Boland, and B.D. Wagner Fluorescence enhancement of curcumin upon inclusion into parent and modified cyclodextrins J Photochem Photobiol 173 2005 230 237
10. S. Balasubramanian, and R.L. Eckert Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancerbinding protein function J Biol Chem 279 23 2004 24007 24014
11. Y. Bamba, Y.S. Yun, A. Kunugi, and H. Inoue Compounds isolated from Curcuma aromatica Salisb. inhibit human P450 enzymes J Nat Med 65 3-4 2011 583 587
12. M. Bernabé-Pineda, M.T. Ramírez-Silva, M. Romero-Romo, E. González-Vergara, and A. Rojas-Hernández Determination of acidity constants of curcumin in aqueous solution and apparent rate constant of its decomposition Spectrochim Acta A Mol Biomol Spectrosc 60 5 2004 1091 1097
13. S. Bisht, G. Feldmann, S. Soni, R. Ravi, C. Karikar, and A. Maitra Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy J Nanobiotechnol 5 2007 3
14. D. Bhowmik Turmeric: a herbal and traditional medicine Arch Appl Sci Res 1 2 2009 86 108
15. R.E. Carroll, R.V. Benya, D.K. Turgeon, S. Vareed, M. Neuman, and L. Rodriguez Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia Cancer Prev Res (Phila) 4 3 2011 354 364
16. H. Chen, J. Wu, M. Sun, C. Guo, A. Yu, and F. Cao N trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin J Liposome Res 22 2 2012 100 109
17. T.Y. Chen, D.Y. Chen, H.W. Wen, J.L. Ou, S.S. Chiou, and J.M. Chen Inhibition of enveloped viruses infectivity by curcumin PLOS ONE 8 May (5) 2013 e62482
18. A.L. Cheng, C.H. Hsu, and J.K. Lin Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 21 2001 2895 2900
19. M. Cruz-Correa, D.A. Shoskes, P. Sanchez, R. Zhao, L.M. Hylind, and S.D. Wexner Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis Clin Gastroenterol Hepatol 4 8 2006 1035 1038
20. S.X. Cui, S.F. Nie, L. Li, C.G. Wang, W.S. Pan, and J.P. Sun Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment Biol Pharm Bull 31 2008 118 125
21. J. Cuomo, G. Appendino, A.S. Dern, E. Schneider, T.P. McKinnon, and M.J. Brown Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation J Nat Prod 74 4 2011 664 669
22. A. Dayton, K. Selvendiran, M.L. Kuppusamy, B.K. Rivera, S. Meduru, and T. Kalai Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties Cancer Biol Ther 10 2010 1027 1032
23. N. Dhillon, B.B. Aggarwal, R.A. Newman, R.A. Wolff, A.B. Kunnumakkara, and J.L. Abbruzzese Phase II trial of curcumin in patients with advanced pancreatic cancer Clin Cancer Res 14 14 2008 4491 4499
24. J. Fang, J. Lu, and A. Holmgren Thioredoxin reductase is irreversibly modified by curcumin: anovel molecular mechanism for its anticancer activity J Biol Chem 280 26 2005 25284 25290
25. J.Y. Fang, C.F. Hung, H.C. Chiu, J.J. Wang, and T.F. Chan Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin J Pharm Pharmacol 55 5 2003 593 601
26. R. Feng, Z. Song, and G. Zhai Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles Int J Nanomed 7 2012 4089 4098
27. S. Gagliardi, S. Ghirmai, K.J. Abel, M. Lanier, S.J. Gardai, and C. Lee Evaluation in vitro of synthetic curcumins as agents promoting monocytic gene expression related to beta-amyloid clearance Chem Res Toxicol 25 2012 101 112
28. G. Galati, O. Sabzevari, J.X. Wilson, and P.J. O'Brien Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics Toxicology 177 2002 91 104
29. Y. Gao, C. Wang, M. Sun, X. Wang, A. Yu, and A. Li In vivo evaluation of curcumin loaded nanosuspensions by oral administration J Biomed Nanotechnol 8 4 2012 659 668
30. Y. Gao, Z. Li, M. Sun, H. Li, C. Guo, and J. Cui Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer Drug Dev Ind Pharm 36 2010 1225 1234
31. S.C. Gupta, J.H. Kim, S. Prasad, and B.B. Aggarwal Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals Cancer Metastasis Rev 29 2010 405 434
32. S.C. Gupta, S. Prasad, J.H. Kim, S. Patchva, L.J. Webb, and I.K. Priyadarsini Multitargeting by curcumin as revealed by molecular interaction studies Nat Prod Rep 28 2011 1937
33. Y. Han, T.M. Chin Tan, and L.Y. Lim In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression Toxicol Appl Pharmacol 230 3 2008 283 289
34. S.I. Hoehle, E. Pfeiffer, A.M. Sólyom, and M. Metzler Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver J Agric Food Chem 54 3 2006 756 764
35. G.M. Holder, J.L. Plummer, and A.J. Ryan The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat Xenibiotica 8 1978 761 768
36. M.T. Huang, T. Lysz, and T. Ferraro Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis Cancer Res 51 1991 813 819
37. B. Jagatha, R.B. Mythri, S. Vali, and M.M.S. Bharath Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies Free Radic Biol Med 44 2008 907 917
38. M. Jaiswal, A.K. Dinda, A. Gupta, and V. Koul Polycaprolactone diacrylate crosslinked biodegradable semi-interpenetrating networks of polyacrylamide and gelatin for controlled drug delivery Biomed Mater 5 6 2010 065014
39. M.K. John, H. Xie, E.C. Bell, and D. Liang Development and pharma-cokinetic evaluation of a curcumin co-solvent formulation Anticancer Res 33 2013 4285 4291
40. A. Jung, K.M. Kyung, K. Bong, Y. Kyu, Y.D. Yan, and C.S. Yong Enhanced oral bioavailability of curcumin via a solid lipid-based self-emulsifying drug delivery system using a spray-drying technique Biol Pharm Bull 34 8 2011 1179 1186
41. J.S. Jurenka Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa. A preclinical and clinical research Altern Med Rev 14 2009 2
42. N.M. Khalil, T.C. do Nascimento, D.M. Casa, L.F. Dalmolin, A.C. de Mattos, and I. Hoss Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats Colloids Surf B Biointerfaces 101 2013 353 360
43. V. Kakkar, S. Singh, D. Singla, and I.P. Kaur Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin Mol Nutr Food Res 55 3 2011 495 503
44. M. Kanai Therapeutic applications of curcumin for patients with pancreatic cancer World J Gastroenterol 20 28 2014 9384 9391
45. M. Kanai, A. Imaizumi, Y. Otsuka, H. Sasaki, M. Hashiguchi, and K. Tsujiko Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Cancer Chemother Pharmacol 69 1 2012 65 70
46. B.J. Kelley, and D.S. Knopman Alternative medicine and Alzheimer disease Neurologist 14 5 2008 299 306
47. A. Khajuria, U. Zutshi, and K.L. Bedi Permeability characteristics of piperine on oral absorption - an active alkaloid from peppers and a bioavailability enhancer Indian J Exp Biol 36 1 1998 46 50
48. S.M. Khopde, K.I. Priyadarsini, S.N. Guha, J.G. Satav, P. Venkatesan, and M.N. Rao Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis Biosci Biotechnol Biochem 64 3 2000 503 509
49. P.M. Kidd Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts Altern Med Rev 14 3 2009 226 246
50. A. Kunwar, S.K. Sandur, M. Krishna, and K.I. Priyadarsini Curcumin mediates time and concentration dependent regulation of redox homeostasis leading to cytotoxicity in macrophage cells Eur J Pharmacol 611 1-3 2009 8 16
51. S.K. Kurd, N. Smith, A. VanVoorhees, A.B. Troxel, V. Badmaev, and J.T. Seykora Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial J Am Acad Dermatol 58 4 2008 625 631
52. M.L. Kuo, T.S. Huang, and J.K. Lin Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells Biochim Biophys Acta 1317 1996 95 100
53. C. Li, Y. Zhang, T. Su, L. Feng, Y. Long, and Z. Chen Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin Int J Nanomed 7 2012 5995 6002
54. C.L. Lin, and J.K. Lin Curcumin: a potential cancer chemopreventive agent through suppressing NF-κB signaling J Cancer 4 2008 11 16
55. A. Liu, H. Lou, L. Zhao, and P. Fan Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin J Pharm Biomed Anal 40 3 2006 720 727
56. C.M. Mach, J.H. Chen, S.A. Mosley, R. Kurzrock, and J.A. Smith Evaluation of liposomal curcumin cytochrome p450 metabolism Anticancer Res 30 3 2010 811 814
57. Madsen B, Hidalgo GV, Hernandez VL. Purification process for improving total yield of curcuminoid colouring agent. United States Patent 6,576,273; 2003.
58. A.P. Majumdar, S. Banerjee, and J. Nautiyal Curcumin synergizes with resveratrol to inhibit colon cancer Nutr Cancer 61 4 2009 544 553
59. S.A. Marathe, I. Dasgupta, D.P. Gnanadhas, and D. Chakravortty Multifaceted roles of curcumin: two sides of a coin! Expert Opin Biol Ther 11 11 2011 1485 1499
60. M.G. Marcu, Y.J. Jung, S. Lee, E.J. Chung, M.J. Lee, and J. Trepel Curcumin is an inhibitor of p300 histone acetylatransferas Med Chem 2 2 2006 169 174
61. T.H. Marczylo, R.D. Verschoyle, D.N. Cooke, P. Morazzoni, W.P. Steward, and A.J. Gescher Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine Cancer Chemother Pharmacol 60 2 2007 171 177
62. L. Mazzarino, C. Travelet, S. Ortega-Murillo, I. Otsuka, I. Pignot-Paintrand, and E. Lemos Senna Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications J Colloid Interface Sci 370 1 2012 58 66
63. P.S. Negi, G.K. Jayaprakasha, L. Jagan Mohan Rao, and K.K. Sakariah Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture J Agric Food Chem 47 1999 4297 4300
64. T. Nishiyama, T. Mae, H. Kishida, M. Tsukagawa, Y. Mimaki, and M. Kuroda Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice J Agric Food Chem 53 2005 959 963
65. T. Okura, M. Ibe, K. Umegaki, K. Shinozuka, and S. Yamada Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells Biol Pharm Bull 33 2 2010 255 259
66. M.H. Pan, T.M. Huang, and J.K. Lin Biotransformation of curcumin through reduction and glucuronidation in mice Drug Metab Dispos 27 4 1999 486 494
67. Y. Panahi, A. Sahebkar, M. Amiri, S.M. Davoudi, F. Beiraghdar, and S.L. Hoseininejad Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomized, double-blind, placebocontrolled trial Br J Nutr 18 2011 1 8
68. S. Perkins, R.D. Verschoyle, K. Hill, and I. Parveen Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS Cancer Epidemiol Biomarkers Prev 11 2002 535 540
69. S. Perkins, R.D. Verschoyle, K. Hill, I. Parveen, M.D. Threadgill, and R.A. Sharma Chemopreventive efficacy and pharmacokinetics of curcumin in the min/mouse, a model of familial adenomatous polyposis Cancer Epidemiol Biomarkers 11 6 2002 535 540
70. K.I. Priyadarsini, D.K. Maity, G.H. Naik, M.S. Kumar, M.K. Unnikrishnan, and J.G. Satav Role of phenolic OH and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin Free Radic Biol Med 35 September (5) 2003 475 484
71. R.J. Price, M.P. Scott, A.M. Giddings, D.G. Walters, R.H. Stierum, and C. Meredith Effect of butylated hydroxytoluene, curcumin, propyl gallate and thiabendazole on cytochrome P450 forms in cultured human hepatocytes Xenobiotica 38 6 2008 574 586
72. H. Rachmawati, C.A. Edityaningrum, and R. Mauludin Molecular inclusion complex of curcumin-beta-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel AAPS PharmSciTech 14 2013 1303 1312
73. Q. Ran, and X. Zhou New methods for isolation of curcumin Shipin Kexue (Beijing) 101 1988 12 15
74. V. Ravindranath, and N. Chandrasekhara Absorption and tissue distribution of curcumin in rats Toxicology 16 3 1980 259 265
75. P.N. Ravindran, K. Nirmal Babu, and K. Sivaraman Turmeric, the genus curcuma 2007 CRC Press/Taylor & Francis Group 235
76. S. Reuter, S.C. Gupta, B. Park, A. Goel, and B.B. Aggarwal Epigenetic changes induced by curcumin and other natural compounds Genes Nutr 6 2 2011 93 108
77. J.M. Ringman, S.A. Frautschy, E. Teng, A.N. Begum, J. Bardens, and M. Beigi Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind,placebo-controlled study Alzheimers Res Ther 4 October (5) 2012 43
78. S.K. Sandur, H. Ichikawa, and M.K. Pandey Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane) Free Radic Biol Med 43 2007 568 580
79. S.H. Sarkar, Y. Li, Z. Wang, and D. Kong NF-kappa signaling pathway and its therapeutic implications in human diseases Int Rev Immunol 27 2008 293 319
80. H. Sasaki, Y. Sunagawa, K. Takahashi, A. Imaizumi, H. Fukuda, and T. Hashimoto Innovative preparation of curcumin for improved oral bioavailability Biol Pharm Bull 34 2011 660 665
81. G. Sethi, B. Sung, A.B. Kunnumakkara, and B.B. Aggarwal Targeting TNF for treatment of cancer and autoimmunity Adv Exp Med Biol 647 2009 37 51
82. G.S. Sidhu, A.K. Singh, D. Thaloor, K.K. Banaudha, G.K. Patnaik, and R.C. Srimal Enhancement of wound healing by curcumin in animals Wound Repair Regen 6 1998 167 177
83. J. Shaikha, D.D. Ankolab, V. Beniwal, D. Singha, and M.N.V. Ravi Kumar Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-times when compared to curcumin administered with piperine as absorption enhancer Eur J Pharm Sci 37 2009 223 230
84. O.P. Sharma Antioxidant activity of curcumin and related compounds Biochem Pharmacol 25 1976 1811 1812
85. R.A. Sharma, S.A. Euden, and S.L. Platton Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clin Cancer Res 10 2004 68476854
86. S. Sharma, S.K. Kulkarni, and K. Chopra Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats Clin Exp Pharmacol Physiol 33 2006 940 945
87. A. Shehzad, F. Wahid, and Y. Sup Lee Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials Arch Pharm Chem Life Sci 9 2010 489 499
88. S. Shishodia, G. Sethi, and B.B. Aggarwal Curcumin: getting back to the roots Ann N Y Acad Sci 1056 2005 206 217
89. S. Shishodia, T. Singh, and M.M. Chaturvedi Modulation of transcription factors by curcumin Adv Exp Med Biol 595 2007 127 148
90. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P.S. Srinivas Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers Planta Med 64 4 1998 353 356
91. S.C. Gupta, S. Prasad, J.H. Kim, S. Patchva, L.J. Webb, and I.K. Priyadarsini Multitargeting by curcumin as revealed by molecular interaction studies Nat Prod Rep 28 2011 1937 1955
92. Y. Sugiyama, S. Kawakishi, and T. Osawa Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin Biochem Pharmacol 52 4 1996 519 525
93. M. Takahashi, D. Kitamoto, T. Imura, H. Oku, K. Takara, and K. Wada Characterization and bioavailability of liposomes containing a ukon extract Biosci Biotechnol Biochem 72 5 2008 1199 1205
94. M. Takahashi, S. Uechi, K. Takara, Y. Asikin, and K. Wada Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin J Agric Food Chem 57 19 2009 9141 9146
95. H.H. Tønnesen, M. Másson, and T. Loftsson Studies of curcumin and curcuminoids XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability Int J Pharm 244 1-2 2002 127 135
96. H.H. Tønnesen Solubility and stability of curcumin in solutions containing alginate and other viscosity modifying macromolecules. Studies of curcumin and curcuminoids. XXX Pharmazie 61 8 2006 696 700
97. Y.M. Tsai, W.L. Chang-Liao, C.F. Chien, L.C. Lin, and T.H. Tsai Effects of polymer molecular weight on relative oral bioavailability of curcumin Int J Nanomed 7 2012 2957 2966
98. S.K. Vareed, M. Kakarala, and M.T. Ruffin Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects Cancer Epidemiol Biomarkers Prev 17 2008 1411 1417
99. S.P. Verma, E. Salamone, and B. Goldin Curcumin and genistein, plant natural products, show sinergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides Biochem Biophys Res Commun 233 3 1997 692 696
100. I. Villegas, S. Sanchez-Fidalgo, and C. Alarcon de la Lastra New mechanisms and therapeutic potential of curcumin for colorectal cancer Mol Nutr Food Res 52 2008 1040 1061
101. L.P. Volak, S. Ghirmai, J.R. Cashman, and M.H. Court Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor Drug Metab Dispos 36 8 2008 1594 1605
102. L.P. Volak, M.J. Hanley, G. Masse, S. Hazarika, J.S. Harmatz, and V. Badmaev Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers Br J Clin Pharmacol 75 2 2013 45062
103. B. Wahlstrom, and G. Blennow A study on the fate of curcumin in the rat Acta Pharmacol Toxicol 43 2 1978 86
104. B. Wahlang, Y.B. Pawar, and A.K. Bansal Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model Eur J Pharm Biopharm 77 2 2011 275 282
105. Y.J. Wang, M.H. Pan, and A.L. Cheng Stability of curcumin in buffer solutions and characterization of its degradation products J Pharm Biomed Anal 15 1997 18671876
106. X. Xie, Q. Tao, Y. Zou, F. Zhang, M. Guo, and Y. Wang PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms J Agric Food Chem 59 2011 9280 9289
107. V.R. Yadav, S. Suresh, K. Devi, and S. Yadav Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model AAPS PharmSciTech 10 2009 3
108. M.M. Yallapu, B.K. Gupta, M. Jaggi, and S.C. Chauhan Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells J Colloid Interface Sci 351 2010 19 29
109. X. Zhang, Q. Chen, Y. Wang, W. Peng, and H. Cai Effects of curcumin on ion channels and transporters Front Physiol 5 March 2014 94
110. L. Zhang, C.T. Lu, W.F. Li, J.G. Cheng, X.Q. Tian, and Y.Z. Zhao Physical characterization and cellular uptake of propylene glycol liposomes in vitro Drug Dev Ind Pharm 38 2012 365 371
111. L. Zhongfa, M. Chiu, J. Wang, W. Chen, W. Yen, and P. Fan-Havard Enhancement of curcumin oral absorption and pharma-cokinetics of curcuminoids and curcumin metabolites in mice Cancer Chemother Pharmacol 69 2012 679 689
112. D.Y. Zhou, N. Ding, Z.Y. Du, X.X. Cui, H. Wang, and X.C. Wei Curcumin analogues with high activity for inhibiting human prostate cancer cell growth andandrogen receptor activation Mol Med Rep 10 3 2014 1315 1322